BNTX vs AMGN: Which Stock is Better?

Side-by-side comparison of Biontech Se and Amgen Inc in 2026

Comparison Updated:

BNTX

Biontech Se

$100.76

AMGN

Amgen Inc

$377.00

Key Metrics Comparison

MetricBNTXAMGNWinner
Market Cap$25.28B$207.92BAMGN
P/E RatioN/A27.10AMGN
EPS (TTM)$N/A$14.23AMGN
Revenue Growth0.2%0.1%BNTX
Gross Margin82.5%70.8%BNTX

Analyze BNTX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BNTX or AMGN a better investment?

Comparing BNTX and AMGN: Biontech Se has a market cap of $25.28B while Amgen Inc has $207.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BNTX and AMGN?

BNTX (Biontech Se) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BNTX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: BNTX or AMGN?

BNTX has higher revenue growth at 0.2% vs 0.1% for AMGN.

Which company is more profitable: BNTX or AMGN?

Biontech Se (BNTX) has higher gross margins at 82.5% compared to 70.8% for AMGN.

Which is the larger company: BNTX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $207.92B compared to $25.28B for BNTX.

Should I buy BNTX or AMGN in 2026?

Both BNTX and AMGN have investment merit. BNTX trades at $100.76 while AMGN trades at $377.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BNTX and AMGN stock?

Key differences: Market Cap ($25.28B vs $207.92B), P/E Ratio (N/A vs 27.1x), Revenue Growth (0.2% vs 0.1%), Gross Margin (82.5% vs 70.8%).

Popular Stock Comparisons